GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (NYSE:A) » Definitions » Market Cap

Agilent Technologies (Agilent Technologies) Market Cap

: $38,897 Mil (As of Today)
View and export this data going back to 1999. Start your Free Trial

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Agilent Technologies's share price for the quarter that ended in Jan. 2024 was $130.1. Agilent Technologies's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 293 Mil. Therefore, Agilent Technologies's market cap for the quarter that ended in Jan. 2024 was $38,125 Mil.

Agilent Technologies's quarterly market cap declined from Jul. 2023 ($35,648 Mil) to Oct. 2023 ($30,197 Mil) but then increased from Oct. 2023 ($30,197 Mil) to Jan. 2024 ($38,125 Mil).

Agilent Technologies's annual market cap declined from Oct. 2021 ($47,562 Mil) to Oct. 2022 ($40,813 Mil) and declined from Oct. 2022 ($40,813 Mil) to Oct. 2023 ($30,197 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Agilent Technologies's Enterprise Value for Today is $39,619 Mil.


Agilent Technologies Market Cap Historical Data

The historical data trend for Agilent Technologies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 23,406.75 [6] => 31,239.54 [7] => 47,561.98 [8] => 40,813.25 [9] => 30,196.75 )
Agilent Technologies Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Market Cap
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,406.75 31,239.54 47,561.98 40,813.25 30,196.75

Agilent Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Market Cap Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45,015.68 39,951.85 35,647.80 30,196.75 38,124.76

Competitive Comparison

For the Diagnostics & Research subindustry, Agilent Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilent Technologies Market Cap Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Market Cap distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's Market Cap falls into.



Agilent Technologies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Agilent Technologies's Market Cap for the fiscal year that ended in Oct. 2023 is calculated as

Market Cap (A: Oct. 2023 )=Share Price (A: Oct. 2023 )*Shares Outstanding (EOP) (A: Oct. 2023 )
=$103.37*292.123
=$30,197

Agilent Technologies's Market Cap for the quarter that ended in Jan. 2024 is calculated as

Market Cap (Q: Jan. 2024 )=Share Price (Q: Jan. 2024 )*Shares Outstanding (EOP) (Q: Jan. 2024 )
=$130.1*293.042
=$38,125

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agilent Technologies  (NYSE:A) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Agilent Technologies Market Cap Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilent Technologies (Agilent Technologies) Business Description

Traded in Other Exchanges
Address
5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Executives
Philip Binns officer: Senior Vice President 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Rodney Gonsalves officer: V.P., Corporate Controller 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Henrik Ancher-jensen officer: Sr. Vice President 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Michael R. Mcmullen officer: CEO and President 5301 STEVENS CREEK BLVD., MS 1A-LC, SANTA CLARA CA 95051
George A Scangos director C/O EXELIXIS INC, 170 HARBOR WAY, SAN FRANCISCO CA 94083
Otis W Brawley director 5203 BRISTOL INDUSTRIAL WAY, BUFORD GA 30518
Mikael Dolsten director 5 GIRALDA FARMS, MADISON NJ 07940
Mala Anand director C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Sue H. Rataj director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Dow R Wilson director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Boon Hwee Koh director C/O AGILENT TECHNOLOGIES, 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Heidi Fields director 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Hans Edgar Bishop director 60 WEST 66TH STREET, 26A, NEW YORK NY 10023
Daniel K Podolsky director 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Padraig Mcdonnell officer: Senior Vice President 5301 STEVENS CREEK BLVD, SANTA CLARA CA 95051